RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AIM ImmunoTech Stock

AIM ImmunoTech Equity 2024

AIM ImmunoTech Equity

10.23 M USD

Ticker

AIM

ISIN

US00901B1052

WKN

A2PREX

In 2024, AIM ImmunoTech's equity was 10.23 M USD, a -73.4% increase from the 38.47 M USD equity in the previous year.

AIM ImmunoTech Aktienanalyse

What does AIM ImmunoTech do?

AIM ImmunoTech Inc is a US-based biotechnology company that focuses on the development of immunotherapeutics and diagnostics for humans and animals. The company has been in operation for over 30 years and specializes in the treatment of viral and autoimmune diseases. AIM ImmunoTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing AIM ImmunoTech's Equity

AIM ImmunoTech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding AIM ImmunoTech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating AIM ImmunoTech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

AIM ImmunoTech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in AIM ImmunoTech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about AIM ImmunoTech stock

What is the equity of AIM ImmunoTech this year?

AIM ImmunoTech has equity of 10.23 M USD this year.

What was the equity of AIM ImmunoTech compared to the previous year?

The equity of AIM ImmunoTech has increased/decreased by -73.4% decreased compared to the previous year.

What impact does a high equity have on investors of AIM ImmunoTech?

A high equity is advantageous for investors of AIM ImmunoTech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of AIM ImmunoTech?

A low equity can be a risk for investors of AIM ImmunoTech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of AIM ImmunoTech affect the company?

An increase in equity of AIM ImmunoTech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of AIM ImmunoTech affect the company?

A reduction in equity of AIM ImmunoTech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of AIM ImmunoTech?

Some factors that can affect the equity of AIM ImmunoTech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of AIM ImmunoTech so important for investors?

The equity of AIM ImmunoTech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can AIM ImmunoTech take to change the equity?

To change equity, AIM ImmunoTech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does AIM ImmunoTech pay?

Over the past 12 months, AIM ImmunoTech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AIM ImmunoTech is expected to pay a dividend of 0 USD.

What is the dividend yield of AIM ImmunoTech?

The current dividend yield of AIM ImmunoTech is .

When does AIM ImmunoTech pay dividends?

AIM ImmunoTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AIM ImmunoTech?

AIM ImmunoTech paid dividends every year for the past 0 years.

What is the dividend of AIM ImmunoTech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AIM ImmunoTech located?

AIM ImmunoTech is assigned to the 'Health' sector.

Wann musste ich die Aktien von AIM ImmunoTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AIM ImmunoTech from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did AIM ImmunoTech pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of AIM ImmunoTech in the year 2023?

In the year 2023, AIM ImmunoTech distributed 0 USD as dividends.

In which currency does AIM ImmunoTech pay out the dividend?

The dividends of AIM ImmunoTech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AIM ImmunoTech

Our stock analysis for AIM ImmunoTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AIM ImmunoTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.